Alma Lasers
10
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
30.0%
3 terminated/withdrawn out of 10 trials
57.1%
-29.4% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Vaginal Changes After CO2 Laser
Role: collaborator
Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat
Role: lead
Safety And Efficacy Investigation Of The Effects Of ClearLift Q-Switched Nd:Yag 1064nm Laser Module In The Treatment Of Facial Skin Wrinkles
Role: lead
Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment of Acne Scars.
Role: lead
Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
Role: lead
The Trio Laser Module for Hair Removal Treatment
Role: lead
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
Role: lead
The Treatment of Acne Vulgaris With Radiofrequency Device
Role: lead
Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study
Role: lead
CO2 Laser in the Treatment of the GSM - (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopause
Role: collaborator
All 10 trials loaded